-
Methyl Trifluoromethanesulfonate (CAS 333-27-7): High-Purity Methylating Agent for Advanced Pharmaceutical Synthesis
In the specialized field of organic chemistry, the precision and efficiency of reactions are paramount. One reagent that stands out for its exceptional reactivity and reliability is Methyl Trifluoromethanesulfonate, commonly known as Methyl Triflate (CAS No. 333-27-7). As a premier methylating ag...Read more -
Great Start
On the eighth day of the first lunar month, we welcome the start of the new year. May 2026 bring a prosperous year, with wealth rolling in! Let’s begin a year full of luck, carrying our New Year’s wishes and striding forward with our heads held high. In the new year, may we face the r...Read more -
METHYL-D3-AMINE HYDROCHLORIDE CAS NO.7436-22-8 explained simply
METHYL-D3-AMINE HYDROCHLORIDE CAS NO.7436-22-8 refers to a special chemical compound. Scientists use it because it contains deuterium, a heavier form of hydrogen. This compound acts as an important building block in chemical synthesis. Many researchers and industry professionals value it for its...Read more -
Shanghai Lizhuo Makes a Grand Appearance at CPHI China 2026: Joining Hands with the Global Pharmaceutical Industry to Create a Healthy Future
Exhibition Information at a Glance: Dates: June 16-18, 2026 Location: Shanghai New International Expo Centre Booth Number: E7G36 At a critical juncture of accelerated transformation in the global pharmaceutical industry, Shanghai Lizh...Read more -
A Key Pharmaceutical Intermediate for Polymer Synthesis Success
Scientists seek precise control in polymer synthesis. The epoxide monomer 1,2-EPOXYTETRADECANE CAS NO.3234-28-4 provides a direct solution. This key pharmaceutical intermediate enables the creation of polymers with predictable molecular weights and narrow polydispersity. Its use is vital in devel...Read more -
Lizhuo Pharmaceutical showcased its high-quality pharmaceutical intermediates at CPHI China 2025.
Shanghai Lizhuo Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the R&D, production, and sales of high-value-added pharmaceutical intermediates and APIs.The company is committed to providing the global pharmaceutical industry with key ma...Read more -
Insufficient self-sufficiency of raw materials in Japan
Active Pharmaceutical Ingredients (APIs) play a key role in the pharmaceutical industry and are the primary basis for the manufacture of all pharmaceuticals. The market size of the Japanese pharmaceutical industry ranks second in Asia. With the increase in R&D expenditure of the pharmaceutica...Read more
